Alkermes ALKS
NASDAQ ALKS
$48.58 -1.60 (-3.20%)
At close: Aug 20, 2026 · 2:01 PM UTC

Alkermes (ALKS) Cash from Operations (QoQ) (2011 - 2026)

Alkermes (ALKS) Cash from Operations (QoQ) (2011 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.94 Bn 42.97 Bn -
2 Teva Pharmaceutical Industries 42.95 Bn 39.30 Bn 2.15 Bn
3 Zoetis 31.58 Bn 29.90 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn
5 United Therapeutics 22.16 Bn 19.49 Bn 683.80 Mn
6 Viatris 18.75 Bn 17.86 Bn 1.46 Bn
7 Neurocrine Biosciences 15.53 Bn 15.14 Bn 935.80 Mn
8 Elanco Animal Health 11.76 Bn 11.23 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.11 Bn 9.95 Bn -
10 Alkermes 8.12 Bn 7.46 Bn 397.90 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 187.60%
Mar 31, 2026 -197.46%
Dec 31, 2025 67.27%
Sep 30, 2025 -32.31%
Jun 30, 2025 52.01%
Mar 31, 2025 -48.10%
Dec 31, 2024 133.36%
Sep 30, 2024 -44.13%
Jun 30, 2024 591.82%
Mar 31, 2024 -80.32%
Dec 31, 2023 7.55%
Sep 30, 2023 -53.78%
Jun 30, 2023 1,112.63%
Mar 31, 2023 -2,134.57%
Dec 31, 2022 67.52%
Sep 30, 2022 127.10%
Jun 30, 2022 -110.64%
Mar 31, 2022 -30.12%
Dec 31, 2021 -62.52%
Sep 30, 2021 150.36%